TEAS Plus New Application

ALPHAQUIN

Stratus Pharmaceuticals Inc.

Trademark/Service Mark Application, Principal Register

PTO Form 1478 (Rev 9/2006)
OMB No. 0651-0009 (Exp 09/30/2008)

Trademark/Service Mark Application, Principal Register

TEAS Plus Application

Serial Number: 77112682
Filing Date: 02/21/2007

NOTE: Data fields with the * are mandatory under TEAS Plus. The wording "(if applicable)" appears where the field is only mandatory under the facts of the particular application.


The table below presents the data as entered.

Input Field
Entered
TEAS Plus YES
MARK INFORMATION
*MARK FILE NAME \\TICRS2\EXPORT12\771\126 \77112682\xml1\FTK0002.JP G
*SPECIAL FORM YES
USPTO-GENERATED IMAGE NO
*COLOR MARK NO
*COLOR(S) CLAIMED
(If applicable)
 
*DESCRIPTION OF THE MARK
(and Color Location, if applicable)
The mark consists of The word "Alphaquin" in a distinctive font. .
PIXEL COUNT ACCEPTABLE YES
PIXEL COUNT 876 x 262
APPLICANT INFORMATION
*OWNER OF MARK Stratus Pharmaceuticals Inc.
*STREET 14377 SW 142ND Street
*CITY Miami
*STATE
(Required for U.S. applicants)
Florida
*COUNTRY United States
*ZIP/POSTAL CODE
(Required for U.S. applicants only)
33186
PHONE 305-254-6793 x229
FAX 305-254-0199
EMAIL ADDRESS XXXX
AUTHORIZED TO COMMUNICATE VIA EMAIL Yes
LEGAL ENTITY INFORMATION
*TYPE CORPORATION
*STATE/COUNTRY OF INCORPORATION Florida
GOODS AND/OR SERVICES AND BASIS INFORMATION
*INTERNATIONAL CLASS 005
       *FIRST USE ANYWHERE DATE At least as early as 01/01/1998
       *FIRST USE IN COMMERCE DATE At least as early as 03/01/1998
*DESCRIPTION Dermatological pharmaceutical products
*FILING BASIS SECTION 1(a)
       *FIRST USE ANYWHERE DATE At least as early as 01/01/1998
       *FIRST USE IN COMMERCE DATE At least as early as 03/01/1998
        SPECIMEN
        FILE NAME(S)
\\TICRS2\EXPORT12\771\126 \77112682\xml1\FTK0003.JP G
       SPECIMEN DESCRIPTION Tradesize Tube in the market today
*DESCRIPTION Medicinal creams for skin care
*FILING BASIS SECTION 1(a)
       *FIRST USE ANYWHERE DATE At least as early as 01/01/1998
       *FIRST USE IN COMMERCE DATE At least as early as 03/01/1998
        SPECIMEN
        FILE NAME(S)
\\TICRS2\EXPORT12\771\126 \77112682\xml1\FTK0003.JP G
       SPECIMEN DESCRIPTION Tradesize Tube in the market today
*DESCRIPTION Pharmaceutical preparations for treating skin disorders
*FILING BASIS SECTION 1(a)
       *FIRST USE ANYWHERE DATE At least as early as 01/01/1998
       *FIRST USE IN COMMERCE DATE At least as early as 03/01/1998
        SPECIMEN
        FILE NAME(S)
\\TICRS2\EXPORT12\771\126 \77112682\xml1\FTK0003.JP G
       SPECIMEN DESCRIPTION Tradesize Tube in the market today
*DESCRIPTION Pharmaceutical preparations for use in dermatology
*FILING BASIS SECTION 1(a)
       *FIRST USE ANYWHERE DATE At least as early as 01/01/1998
       *FIRST USE IN COMMERCE DATE At least as early as 03/01/1998
        SPECIMEN
        FILE NAME(S)
\\TICRS2\EXPORT12\771\126 \77112682\xml1\FTK0003.JP G
       SPECIMEN DESCRIPTION Tradesize Tube in the market today
*DESCRIPTION Pharmaceutical products and preparations for chloasma
*FILING BASIS SECTION 1(a)
       *FIRST USE ANYWHERE DATE At least as early as 01/01/1998
       *FIRST USE IN COMMERCE DATE At least as early as 03/01/1998
        SPECIMEN
        FILE NAME(S)
\\TICRS2\EXPORT12\771\126 \77112682\xml1\FTK0003.JP G
       SPECIMEN DESCRIPTION Tradesize Tube in the market today
*DESCRIPTION Pharmaceutical products and preparations for pregnancy blemishes
*FILING BASIS SECTION 1(a)
       *FIRST USE ANYWHERE DATE At least as early as 01/01/1998
       *FIRST USE IN COMMERCE DATE At least as early as 03/01/1998
        SPECIMEN
        FILE NAME(S)
\\TICRS2\EXPORT12\771\126 \77112682\xml1\FTK0003.JP G
       SPECIMEN DESCRIPTION Tradesize Tube in the market today
*DESCRIPTION Pharmaceutical products and preparations for preventing skin blemishes during pregnancy
*FILING BASIS SECTION 1(a)
       *FIRST USE ANYWHERE DATE At least as early as 01/01/1998
       *FIRST USE IN COMMERCE DATE At least as early as 03/01/1998
        SPECIMEN
        FILE NAME(S)
\\TICRS2\EXPORT12\771\126 \77112682\xml1\FTK0003.JP G
       SPECIMEN DESCRIPTION Tradesize Tube in the market today
ADDITIONAL STATEMENTS INFORMATION
*TRANSLATION
(if applicable)
 
*TRANSLITERATION
(if applicable)
 
*CLAIMED PRIOR REGISTRATION
(if applicable)
 
*CONSENT (NAME/LIKENESS)
(if applicable)
 
*CONCURRENT USE CLAIM
(if applicable)
 
CORRESPONDENCE INFORMATION
*NAME Stratus Pharmaceuticals Inc.
FIRM NAME Stratus Pharmaceuticals Inc.
*STREET 14377 SW 142ND Street
* CITY Miami
* STATE
(Required for U.S. applicants)
Florida
* COUNTRY United States
* ZIP/POSTAL CODE
(Required for U.S. applicants only)
33186
PHONE 305-254-6793 x229
FAX 305-254-0199
* EMAIL ADDRESS jbilloch@bellsouth.net
*AUTHORIZED TO COMMUNICATE VIA EMAIL Yes
FEE INFORMATION
NUMBER OF CLASSES 1
FEE PER CLASS 275
TOTAL FEE DUE 275
SIGNATURE INFORMATION
* SIGNATURE /jbilloch/
* SIGNATORY'S NAME Juan Carlos Billoch
SIGNATORY'S POSITION VP, Operations
* DATE SIGNED 02/21/2007
FILING INFORMATION SECTION
SUBMIT DATE Wed Feb 21 16:33:27 EST 2007
TEAS STAMP USPTO/FTK-XX.XX.XXX.XX-20
070221163327778169-771126
82-360d71d61663bbc44f42e9
6255a8d313e1d-CC-440-2007
0221160038508197



PTO Form 1478 (Rev 9/2006)
OMB No. 0651-0009 (Exp 09/30/2008)


Trademark/Service Mark Application, Principal Register

TEAS Plus Application

Serial Number: 77112682
Filing Date: 02/21/2007



To the Commissioner for Trademarks:
MARK: (Stylized and/or Design, see mark)
The applicant is not claiming color as a feature of the mark. The mark consists of The word "Alphaquin" in a distinctive font. .

The applicant, Stratus Pharmaceuticals Inc., a corporation of Florida, having an address of 14377 SW 142ND Street, Miami, Florida, United States, 33186, requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended.

For specific filing basis information for each item, you must view the display within the Input Table.
       International Class 005:  Dermatological pharmaceutical products; Medicinal creams for skin care; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical products and preparations for chloasma; Pharmaceutical products and preparations for pregnancy blemishes; Pharmaceutical products and preparations for preventing skin blemishes during pregnancy

If the applicant is filing under Section 1(b), intent to use, the applicant declares that it has a bona fide intention to use or use through the applicant's related company or licensee the mark in commerce on or in connection with the identified goods and/or services. 15 U.S.C. Section 1051(b), as amended.

If the applicant is filing under Section 1(a), actual use in commerce, the applicant declares that it is using the mark in commerce, or the applicant's related company or licensee is using the mark in commerce, on or in connection with the identified goods and/or services. 15 U.S.C. Section 1051(a), as amended.

If the applicant is filing under Section 44(d), priority based on foreign application, the applicant declares that it has a bona fide intention to use the mark in commerce on or in connection with the identified goods and/or services, and asserts a claim of priority based on a specified foreign application(s). 15 U.S.C. Section 1126(d), as amended.

If the applicant is filing under Section 44(e), foreign registration, the applicant declares that it has a bona fide intention to use the mark in commerce on or in connection with the identified goods and/or services, and submits a copy of the supporting foreign registration(s), and translation thereof, if appropriate. 15 U. S.C. Section 1126(e), as amended.


Correspondence Information: Stratus Pharmaceuticals Inc.
14377 SW 142ND Street
Miami, Florida 33186
305-254-6793 x229(phone)
305-254-0199(fax)
jbilloch@bellsouth.net (authorized)

A fee payment in the amount of $275 will be submitted with the application, representing payment for 1 class(es).

Declaration

The undersigned, being hereby warned that willful false statements and the like so made are punishable by fine or imprisonment, or both, under 18 U.S.C. Section 1001, and that such willful false statements, and the like, may jeopardize the validity of the application or any resulting registration, declares that he/she is properly authorized to execute this application on behalf of the applicant; he/she believes the applicant to be the owner of the trademark/service mark sought to be registered, or, if the application is being filed under 15 U.S.C. Section 1051(b), he/she believes applicant to be entitled to use such mark in commerce; to the best of his/her knowledge and belief no other person, firm, corporation, or association has the right to use the mark in commerce, either in the identical form thereof or in such near resemblance thereto as to be likely, when used on or in connection with the goods/services of such other person, to cause confusion, or to cause mistake, or to deceive; and that all statements made of his/her own knowledge are true; and that all statements made on information and belief are believed to be true.


Signature: /jbilloch/   Date: 02/21/2007
Signatory's Name: Juan Carlos Billoch
Signatory's Position: VP, Operations

RAM Sale Number: 440
RAM Accounting Date: 02/22/2007

Serial Number: 77112682
Internet Transmission Date: Wed Feb 21 16:33:27 EST 2007
TEAS Stamp: USPTO/FTK-XX.XX.XXX.XX-20070221163327778
169-77112682-360d71d61663bbc44f42e96255a
8d313e1d-CC-440-20070221160038508197


TEAS Plus New Application [image/jpeg]

TEAS Plus New Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed